two things need to happen 1. more clarity on Fi
Post# of 75001
1. more clarity on Fitwhey sales channel, pretty logical to be next in the podcast.
2. more clarify on whether CBD Alimento skus are in the hands of mexican government FDA, I assume it is hard to estimate when they will be approved; they did say Q4 now in the 10Q today. A ball park of how mexican government FDA takes to get the work done for similar product will do. Yes CBD is new, but just use energy drinks for example.
The negative:
if no CBD Alimento funds coming in for Q4, most likely one more GHS financing for Q4.
Positives to look forward to for Christmas Q4 report
#1. more hempd sales
#2. more eagle spirit contracts
#3. first evidence of fitwhey revenue stream come into play
#4. CBD Alimentos deal - uncertain at this point. The podcast brought too much hope, so i think share price will reflect the Q4 estimate on Monday.
I'd like to see a revenue breakdown of the different brands in Q4.
#4 is what everyone is waiting for to really help build shareholder confidence. Non-dilutive money to continue reinvent the company is what will attract new shareholders to gamble on an emerging sector
The long game of this company is building its market reach and becomes an attractive candidate to be partnered with by a marijuana company once US legalizes marijuana at the federal level.